PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 67 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $212,000 | -9.0% | 10,867 | -17.6% | 0.02% | -8.0% |
| Q2 2020 | $233,000 | +65.2% | 13,189 | -23.0% | 0.02% | +108.3% |
| Q1 2020 | $141,000 | +18.5% | 17,122 | +1.0% | 0.01% | +20.0% |
| Q4 2019 | $119,000 | -46.4% | 16,947 | -8.4% | 0.01% | -47.4% |
| Q3 2019 | $222,000 | -9.4% | 18,511 | -8.6% | 0.02% | -9.5% |
| Q2 2019 | $245,000 | -5.4% | 20,244 | -1.7% | 0.02% | 0.0% |
| Q1 2019 | $259,000 | +46.3% | 20,599 | -21.8% | 0.02% | +50.0% |
| Q4 2018 | $177,000 | -50.1% | 26,335 | -29.4% | 0.01% | -36.4% |
| Q3 2018 | $355,000 | +50.4% | 37,299 | +6.2% | 0.02% | +57.1% |
| Q2 2018 | $236,000 | – | 35,133 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |